Difference between revisions of "Part:BBa K1632012:Design"
(→Result) |
JunKawamura (Talk | contribs) (→Materials and Methods) |
||
(2 intermediate revisions by 2 users not shown) | |||
Line 15: | Line 15: | ||
All the samples were DH5α strain with antibiotic resistance to ampicillin and kanamycin.<br> | All the samples were DH5α strain with antibiotic resistance to ampicillin and kanamycin.<br> | ||
− | (1) PBAD/araC_fimB(wild-type) (pSB6A1) + ''fim'' switch[default ON](wild-type) | + | (1) PBAD/araC_fimB(wild-type) (pSB6A1) + ''fim'' switch[default ON](wild-type)_rbs_''gfp'' (pSB3K3) <br> |
− | (2) PBAD/araC_fimB(wild-type) (pSB6A1) + ''fim'' switch[default OFF](wild-type) | + | (2) PBAD/araC_fimB(wild-type) (pSB6A1) + ''fim'' switch[default OFF](wild-type)_rbs_''gfp'' (pSB3K3) <br> |
− | (3) pSB6A1 + ''fim'' switch[default ON](wild-type) | + | (3) pSB6A1 + ''fim'' switch[default ON](wild-type)_rbs_''gfp'' (pSB3K3) …positive control 1<br> |
− | (4) pSB6A1 + ''fim'' switch[default OFF](wild-type) | + | (4) pSB6A1 + ''fim'' switch[default OFF](wild-type)_rbs_''gfp'' (pSB3K3) …negative control 1<br> |
− | (5) PBAD/araC_fimB(wild-type) (pSB6A1) + | + | (5) PBAD/araC_fimB(wild-type) (pSB6A1) + J23119_rbs_''gfp''(pSB3K3) …positive control 2 <br> |
− | (6) PBAD/araC_fimB(wild-type) (pSB6A1) + | + | (6) PBAD/araC_fimB(wild-type) (pSB6A1) + rbs_''gfp''(pSB3K3) …negative control 2 <br> |
[[Image:Tokyo_Tech_FimB_assay.png |thumb|center|900px|<b>Fig. 1. </b>Plasmids]]<br> | [[Image:Tokyo_Tech_FimB_assay.png |thumb|center|900px|<b>Fig. 1. </b>Plasmids]]<br> | ||
Line 50: | Line 50: | ||
=====Results===== | =====Results===== | ||
− | [[Image:Tokyo_Tech_FimB_assay_Results.png |thumb|center|700px|<b>Fig. | + | [[Image:Tokyo_Tech_FimB_assay_Results.png |thumb|center|700px|<b>Fig. w. </b>The histograms of the samples measured by flow cytometer]]<br> |
====Supplemental experiments==== | ====Supplemental experiments==== | ||
Line 76: | Line 76: | ||
=====Results===== | =====Results===== | ||
− | [[Image:Tokyo_Tech_FLA_colony_FimB.png |thumb|center|600px|<b>Fig. | + | [[Image:Tokyo_Tech_FLA_colony_FimB.png |thumb|center|600px|<b>Fig. 3. </b> Determination of percemtage of [ON] state and colony formation using plasmid mixture extracted cell expressing FimB.]]<br> |
− | [[Image:Tokyo_Tech_FImB_sequence.png |thumb|center|600px|<b>Fig. | + | [[Image:Tokyo_Tech_FImB_sequence.png |thumb|center|600px|<b>Fig. 4. </b> DNA sequencing results of <i>fim</i> switch(wild-type)]]<br> |
+ | |||
+ | ===More information=== | ||
+ | |||
+ | For more information, see [[http://2015.igem.org/Team:Tokyo_Tech/Project Our work in Tokyo_Tech 2015 wiki]], [[http://2015.igem.org/Team:Tokyo_Tech/Experiment/ssrA_tag_degradation_assay About ssrA-tag]], [[http://2015.igem.org/Team:Tokyo_Tech/Experiment/Overview_of_fim_inversion_system About ''fim'' inversion system]] | ||
+ | |||
===Source=== | ===Source=== |
Latest revision as of 03:59, 19 September 2015
PBAD/araC_rbs_fimB(wild-type)
- 10COMPATIBLE WITH RFC[10]
- 12INCOMPATIBLE WITH RFC[12]Illegal NheI site found at 1205
- 21INCOMPATIBLE WITH RFC[21]Illegal BamHI site found at 1144
- 23COMPATIBLE WITH RFC[23]
- 25INCOMPATIBLE WITH RFC[25]Illegal AgeI site found at 979
- 1000INCOMPATIBLE WITH RFC[1000]Illegal SapI site found at 961
Design Notes
sequence confirmed
Materials and Methods
Construction
All the samples were DH5α strain with antibiotic resistance to ampicillin and kanamycin.
(1) PBAD/araC_fimB(wild-type) (pSB6A1) + fim switch[default ON](wild-type)_rbs_gfp (pSB3K3)
(2) PBAD/araC_fimB(wild-type) (pSB6A1) + fim switch[default OFF](wild-type)_rbs_gfp (pSB3K3)
(3) pSB6A1 + fim switch[default ON](wild-type)_rbs_gfp (pSB3K3) …positive control 1
(4) pSB6A1 + fim switch[default OFF](wild-type)_rbs_gfp (pSB3K3) …negative control 1
(5) PBAD/araC_fimB(wild-type) (pSB6A1) + J23119_rbs_gfp(pSB3K3) …positive control 2
(6) PBAD/araC_fimB(wild-type) (pSB6A1) + rbs_gfp(pSB3K3) …negative control 2
Flow cytometer
Assay protocol
1. Prepare overnight cultures for each sample in 3 mL of LB medium containing ampicillin (50 microg / mL), kanamycin (30 microg / mL) and glucose (final concentration is 0.5 %) at 37 ℃ for 12h.
2. Make a 1:100 dilution in 3 mL of fresh LB containing Amp, Kan and glucose (final concentration is 0.5 %).
3. Incubate the cells at 37 ℃, shaking at 180 rpm until the observed OD590 reaches 0.4 (Fresh Culture).
4. After the incubation, take 1 mL of the samples, and centrifuge at 5000x g, 1 min, 25 ℃
5. Remove the supernatant.
6. Suspend the pellet in 1 mL of LB containing Amp and Kan, and centrifuge at 5000x g, 1 min, 25 ℃
7. Remove the supernatant.
8. Suspend the pellet in 1 mL of LB containing Amp and Kan, and centrifuge at 5000x g, 1 min, 25 ℃
9. Remove the supernatant.
10. Suspend the pellet in 1 mL of LB containing Amp and Kan.
11. Add 30 microL of suspension in the following medium.
① 3 mL of LB containing Amp, Kan, glucose (final concentration is 0.5 %) and 30 microL of sterile water
② 3 mL of LB containing Amp, Kan and 30 microL of 2 mM arabinose (final concentration of arabinose is 20 microM)
③ 3 mL of LB containing Amp, Kan and 30 microL of 20 mM arabinose (final concentration of arabinose is 200 microM)
④ 3 mL of LB containing Amp, Kan and 30 microL of 500 mM arabinose (final concentration of arabinose is 5 mM)
※ As for (3) and (4), the suspension were added only in medium ① and ④.
12. Incubate the samples at 37 ℃, shaking at 180 rpm for 6.5 hours. (Measure OD590 of all the samples every hour.)
13. After the incubation, take the samples, and centrifuge at 9000x g, 1min, 4℃.
14. Remove the supernatant.
15. Add 1 mL of filtered PBS (phosphate-buffered saline) and suspend. (The ideal of OD is 0.3)
16. Dispense all of each suspension into a disposable tube through a cell strainer.
17. Use flow cytometer to measure the fluorescence of GFP. (We used BD FACSCaliburTM Flow Cytometer of Becton, Dickenson and Company.)
Results
Supplemental experiments
Assay protocol
1. After the assay of “Arabinose dependent FimE expression”, miniprep cell culture ((1)-①, (1)-③, (2)-① and (2)-③) of leftover as here.(https://parts.igem.org/Help:Protocols/Miniprep)
2. Turn on water bath to 42℃.
3. Take competent DH5alpha strain from -80℃ freezer and leave at rest on ice.
4. Add 3 µl of each plasmids in a 1.5 ml tube.
5. Put 25 µl competent cell into each 1.5 ml tubes with plasmid.
6. Incubate on ice for 15 min.
7. Put tubes with DNA and competent cells into water bath at 42℃ for 30 seconds.
8. Put tubes back on ice for 2 minutes.
9. Add 125 µl of SOC medium. Incubate tubes for 30 minutes at 37℃.
10. Make a 1:5 dilution in 150 µl of fresh SOC medium.
11. Spread about 100 µl of the resulting culture of LB plate containing kanamycin.
12. Incubate LB plate for 14-15 hours at 37℃.
13. Set the plate reader to measure GFP.
14. Scan the each plates with the plate reader. (We used FujiFilm FLA-5100 Fluorescent Image Analyzer from FUJIFilm Life Science.)
15. Analyze the scanning data by changing the scale type (Bezier) and adjusting the range. (We analyzed by using the software, Multi Gauge ver. 2.0 from FUJIFilm Life Science.)
16. Counted out the all colonies and those with fluorescence.
17. Prepare three overnight cultures for each sample in 3 mL of LB medium containing kanamycin (30 microg / mL) shaking at 180 rpm for 12h.
18. Miniprep each samples and ask DNA sequencing of each samples for Biomaterial Analysis Center, Technical Department.
Results
More information
For more information, see http://2015.igem.org/Team:Tokyo_Tech/Project Our work in Tokyo_Tech 2015 wiki, http://2015.igem.org/Team:Tokyo_Tech/Experiment/ssrA_tag_degradation_assay About ssrA-tag, http://2015.igem.org/Team:Tokyo_Tech/Experiment/Overview_of_fim_inversion_system About ''fim'' inversion system
Source
PCR from MG1655
References
[1]Hung M. et al. (2014) Modulating the frequency and bias of stochastic switching to control phenotypic variation. Nat Commun 5:4574. doi:10.1038/ncomms5574
[2]Timothy S. Ham et al. (2006) A Tightly Regulated Inducible Expression System Utilizing the fim Inversion Recombination Switch. Biotechnol Bioeng 94(1):1-4